NCT00506025

Brief Summary

This study is to help determine if drinking cranberry juice can decrease risk for asymptomatic bacteriuria (ASB). ASB occurs when there are bacteria in the urine without any symptoms. It will also see if there is a difference in this effect between pregnant and non-pregnant women.This research project is also designed to see what happens to bacterial binding to the lining of the bladder after drinking cranberry juice when special problems occur with pregnancy such as diabetes (a sugar metabolism problem) or ASB is already occurring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 25, 2007

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

June 8, 2010

Completed
Last Updated

December 18, 2017

Status Verified

November 1, 2017

Enrollment Period

1.5 years

First QC Date

July 24, 2007

Results QC Date

December 3, 2009

Last Update Submit

November 17, 2017

Conditions

Keywords

PregnancyCranberryAsymptomatic Bacteruria

Outcome Measures

Primary Outcomes (1)

  • Antimicrobial Activity of Urine From Pregnant Subjects Following Cranberry Juice Cocktail (CJC)

    The primary outcome measure was the measurement of bacteriuria in study subject urine, defined as having a urine culture with 100,000 or more of a single uropathogen (measured as cfu per ml).

    7 months, from enrollment at 3 months of pregnancy to delivery

Study Arms (3)

Cranberry 2xday

ACTIVE COMPARATOR

Cranberry juice (C) two times daily, a.m. and p.m.

Dietary Supplement: Cranberry Juice

Cranberry + Placebo

ACTIVE COMPARATOR

De-Activated Cranberry juice in the am, then placebo (P) in the pm

Dietary Supplement: Cranberry Juice

Placebo 2xday

PLACEBO COMPARATOR

Placebo in the form of juice two times daily in the a.m. and p.m.

Dietary Supplement: De-Activated Cranberry juice

Interventions

Cranberry JuiceDIETARY_SUPPLEMENT

Low-calorie, Low-carbohydrate content 8 oz dose of Cranberry juice

Cranberry + PlaceboCranberry 2xday

De-Activated Cranberry juice in the am, then placebo (P) in the pm

Placebo 2xday

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Intrauterine pregnancy
  • Documented fetal viability (either by fetal heart tones present by Doppler auscultation, or by ultrasonic visualization of cardiac motion
  • Estimated gestational age by last menstrual period and/or by ultrasonographic fetal measurements of 16 weeks or less

You may not qualify if:

  • Suspected non-viable or ectopic gestation
  • Patient desires pregnancy termination
  • Significant underlying medical complication, such as chronic hypertension, insulin-requiring diabetes, chronic renal failure, cardiac disease, sickle cell disease, etc.
  • Maternal age less than 18 years
  • Patient is currently on or has received within the two weeks prior to enrollment antimicrobial therapy for reasons other than urinary tract infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Irvine Medical Center

Orange, California, 92868, United States

Location

Limitations and Caveats

Our study methodology could have been improved with a series of timed urine collections such as collections at pre-treatment, 2, 4 and 6 hours after ingestion of the cranberry juice cocktail and placebo to determine time of maximal effect.

Results Point of Contact

Title
Deborah A. Wing, MD
Organization
University of California Irvine Medical Center

Study Officials

  • Deborah A Wing, MD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Division of Maternal-Fetal Medicine, Obstetrics & Gynecology, University of California, Irvine School of Medicine

Study Record Dates

First Submitted

July 24, 2007

First Posted

July 25, 2007

Study Start

August 1, 2006

Primary Completion

February 1, 2008

Study Completion

February 1, 2008

Last Updated

December 18, 2017

Results First Posted

June 8, 2010

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Locations